Search
for
Sort by
Research 271–300 of 697
- Fiber Implantation for Pattern Baldness
- Ethnic Hair Disorders
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Dermatologic Reactions to Targeted Therapy
- Niosomes as Carrier in Dermal Drug Delivery
- Green hair discoloration due to selenium sulfide
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Exploring the Multifaceted Impact of Acne on Quality of Life and Well-Being
- Psychoactive drugs and skin
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- An overview of zinc and its importance in dermatology-Part II: The association of zinc with some dermatologic disorders
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Polycystic ovary syndrome: a dermatologic approach
- Skin problems in the long‐distance runner 2500 years after the Battle of Marathon
- Treatment of hyperandrogenism in women
- The Role of Cytochrome P-450 in Dermatology
- Hair Growth Promoting Effect of 4HGF Encapsulated with PGA Nanoparticles (PGA-4HGF) by β-Catenin Activation and Its Related Cell Cycle Molecules
- Potential applications of topical oxygen therapy in dermatology
- Multiple apocrine hidrocystomas successfully treated with botulinum toxin A
- Skin eruptions specific to pregnancy: an overview
- Granulocyte Colony-Stimulating Factor Treatment of Cyclic Neutropenia With Recurrent Oral Aphthae
- Acne in Dark Skin
- Materials, Syntheses and Biomedical Applications of Nano-Quercetin Formulations: A Comprehensive Literature Review
- In silico analysis of ethyl acetate Bruguiera gymnorhiza leaf extracts as an anti-inflammatory agent
- Characterization of Spanlastic System Loaded Green Tea Extract as Antioxidant for Skin
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- K15 promoter-driven enforced expression of NKIRAS exhibits tumor suppressive activity against the development of DMBA/TPA-induced skin tumors
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders